Skip to main content

Table 2 Prevalence [%, (n)] of chronic conditions and medication use among people reporting NSAID use

From: Cause for concern in the use of non-steroidal anti-inflammatory medications in the community -a population-based study

  Reported NSAID use    Ns-NSAID    COX-2 inhibitor   
  No Yes p No Yes   No Yes  
Chronic conditions, % (n)          
Joint pain          
Diagnosed as arthritis 23.4 (649) 70.8 (247) < 0.01 26.9 (796) 57.5 (100) < 0.01 25.3 (745) 83.4 (151) < 0.01
Not diagnosed as arthritis 39.4 (1095) 22.6 (79)   37.8 (1117) 32.8 (57)   39.0 (1151) 12.7 (23)  
Cardiovascular disease/stroke 8.7 (240) 17.2 (60) < 0.01 9.4 (276) 13.8 (24) 0.05 9.0 (264) 20.0 (36) < 0.01
MI/angina 6.5 (182) 12.0 (42) < 0.01 7.0 (208) 9.2 (16) 0.28 6.7 (198) 14.4 (26) < 0.01
> 15% 10 year CVD risk 14.9 (324) 20.7 (56) 0.01 15.4 (355) 17.9 (25) 0.44 15.1 (348) 23.7 (32) < 0.01
Hypertension* 40.3 (1137) 60.8 (217) < 0.01 42.0 (1261) 52.8 (93) < 0.01 41.0 (1226) 68.4 (128) < 0.01
Kidney disease** 20.6 (576) 30.8 (109) < 0.01 21.6 (644) 23.4 (41) 0.58 20.8 (616) 37.3 (69) < 0.01
Primary care provider visits in previous year          
0 7.9 (219) 2.3 (8) < 0.01 7.4 (220) 4.0 (7) < 0.01 7.7 (226) 0.6 (1) < 0.01
1-4 53.0 (1474) 29.4 (103)   51.5 (1521) 32.2 (56)   51.9 (1530) 26.0 (47)  
≥ 5 39.1 (1087) 68.3 (239)   41.1 (1215) 63.8 (111)   40.5 (1193) 73.5 (133)  
Medications          
Anti-hypertensives 26.6 (749) 40.9 (146) < 0.01 27.9 (836) 33.5 (59) 0.11 27.0 (806) 47.6 (89) < 0.01
Diuretics 3.6 (101) 9.0 (32) < 0.01 4.1 (123) 5.7 (10) 0.31 3.7 (110) 12.3 (23) < 0.01
ACE inhibitors 11.3 (319) 12.0 (43) 0.69 11.2 (336) 14.8 (26) 0.15 11.5 (344) 9.6 (18) 0.43
Gastro-esophageal reflux 12.3 (347) 31.9 (114) < 0.01 14.0 (419) 23.9 (42) < 0.01 12.9 (386) 40.1 (75) < 0.01
  1. *Hypertension: systolic ≥ 140 mm Hg and/or diastolic ≥ 90 mm Hg or use of anti-hypertensive medication.
  2. **Kidney disease: GFR < 60 ml/min/1.73 m2, GFR > 60 and proteinuria.